SCHEMBL3848636

SCHEMBL3848636

CC(C)Cn1c2ccccc2c2cc(-c3ccccc3)ccc21

nearest known ligand 0.63

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 3/20 0.63
ALDH1A1 P00352 4/20 0.59
HPGD P15428 2/20 0.59
TSPO P30536 3/20 0.54
DNM1 Q05193 3/20 0.52
NPY5R Q15761 3/20 0.46
BACE1 P56817 2/20 0.46
MAPT P10636 2/20 0.44
POLB P06746 1/20 0.44
RORC P51449 1/20 0.44
SMN1; SMN2 Q16637 2/20 0.44
HSD17B10 Q99714 2/20 0.44
TDP1 Q9NUW8 2/20 0.44
TSHR P16473 1/20 0.44
L3MBTL1 Q9Y468 1/20 0.44
MEN1 O00255 1/20 0.43
MAPK1 P28482 1/20 0.43
HTT P42858 1/20 0.43
HBB P68871 1/20 0.43
KMT2A Q03164 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2803193 0.87 ALDH1A1 (0.56) KDM4EALDH1A1HPGDTSPODNM1
SCHEMBL2801853 0.85 ALDH1A1 (0.54) KDM4EALDH1A1HPGDTSPODNM1
SCHEMBL2801687 0.84 ALDH1A1 (0.56) KDM4EALDH1A1HPGDTSPODNM1
SCHEMBL2800760 0.84 KDM4E (0.50) KDM4EALDH1A1HPGDTSPODNM1
SCHEMBL13562924 0.83 HPGD (0.65) KDM4EALDH1A1HPGDDNM1NPY5R
SCHEMBL16744061 0.83 HPGD (0.52) KDM4EALDH1A1HPGDTSPODNM1
SCHEMBL2800361 0.83 BACE1 (0.63) KDM4EALDH1A1HPGDDNM1BACE1
SCHEMBL29643235 0.83 BACE1 (0.63) KDM4EALDH1A1HPGDDNM1BACE1
SCHEMBL2613140 0.82 KDM4E (0.46) KDM4EALDH1A1HPGDTSPODNM1
SCHEMBL2800147 0.82 ALDH1A1 (0.51) KDM4EALDH1A1HPGDTSPODNM1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9899612-B2 Organic electroluminescent materials and devices UNIVERSAL DISPLAY CORPORATION (US) 2018-02-20 US disclosed
US-20140284585-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES UNIVERSAL DISPLAY CORPORATION 2014-09-25 US disclosed
US-8778508-B2 Light-emitting organometallic complexes UNIVERSAL DISPLAY CORPORATION (US) 2014-07-15 US disclosed
US-8519130-B2 Method for synthesis of iriduim (III) complexes with sterically demanding ligands UNIVERSAL DISPLAY CORPORATION (US) 2013-08-27 US disclosed
WO-2009073246-A1 METHOD FOR THE SYNTHESIS OF IRIDIUM (III) COMPLEXES WITH STERICALLY DEMANDING LIGANDS UNIVERSAL DISPLAY CORPORATION (US) 2009-06-11 WO disclosed
WO-2009073245-A1 LIGHT-EMITTING ORGANOMETALLIC COMPLEXES UNIVERSAL DISPLAY CORPORATION (US) 2009-06-11 WO disclosed
US-20090124805-A1 METHOD FOR SYNTHESIS OF IRIDUIM (III) COMPLEXES WITH STERICALLY DEMANDING LIGANDS UNIVERSAL DISPLAY CORPORATION 2009-05-14 US disclosed
US-20090108737-A1 LIGHT-EMITTING ORGANOMETALLIC COMPLEXES UNIVERSAL DISPLAY CORPORATION 2009-04-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090108737-A1 LIGHT-EMITTING ORGANOMETALLIC COMPLEXES CRY1, LAGE3, CRY2 KDM4E 1922/4885ALDH1A1 2005/4885HPGD 3835/4885
US-20090124805-A1 METHOD FOR SYNTHESIS OF IRIDUIM (III) COMPLEXES WITH STERICALLY DEMANDING LIGANDS PAICS, ITPA, MPI KDM4E 4012/4885ALDH1A1 2362/4885HPGD 2978/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.